Welcome to our dedicated page for Dss news (Ticker: DSS), a resource for investors and traders seeking the latest updates and insights on Dss stock.
DSS, Inc. (NYSE American: DSS) generates news across a wide range of sectors, reflecting its role as a multinational company with diversified business lines in packaging, biohealth innovation, financial services, alternative trading, and real estate. The company’s press releases and regulatory disclosures highlight strategic transactions, capital markets developments, operational milestones, and portfolio optimization efforts.
News about DSS often covers corporate strategy and portfolio management, including spin-offs, asset sales, and transactions involving key subsidiaries. Examples include the sale of the Celios air purification asset to Impact BioMedical Inc., as well as a definitive merger agreement under which Impact BioMedical will be acquired through a reverse merger with Dr. Ashleys Limited, resulting in a new public company. These items illustrate DSS’s stated approach of unlocking value by advancing subsidiaries toward independent public listings and other exit opportunities.
Investors and followers of DSS can also expect updates on financial performance and corporate actions. The company reports on revenue trends, cash flow improvements, debt reduction, and asset monetization, such as the sale of a real estate facility and growth in rental income. Leadership communications, including letters to shareholders and announcements of executive appointments, provide additional context on strategic priorities, cost reduction initiatives, and the focus on core growth verticals.
Because DSS has subsidiaries in securities and investment management, its news flow includes developments at entities like Sentinel Brokers Company, Inc. and AmericaFirst Funds. These updates may involve regulatory approvals, such as FINRA authorization for underwriting activities, changes to mutual fund boards, and expansion of capital markets capabilities. For a comprehensive view of DSS-related developments, readers can use this news page to follow corporate strategy, subsidiary activity, and key financial and regulatory events over time.
DSS, Inc. (NYSE American: DSS) announces a letter to shareholders highlighting its transformative journey since 2019. The company's assets have surged from $16.2 million to over $219 million, fueled by acquisitions and divestitures. DSS plans an acquisition of True Partner Capital, boosting its securities business with $1.7 billion in assets under management. The company has raised over $121 million through public offerings and is pursuing spinoffs to enhance shareholder value. With strong growth in medical real estate and direct selling, DSS anticipates significant revenue increases in 2022.
DSS, a multinational company with diverse business interests, will present at the Aegis Capital Corp. Virtual Conference on February 25 at 9:30 a.m. EST. The conference is scheduled from February 23 to 25, operating daily from 8:30 a.m. to 5 p.m. EST. Interested parties can access DSS's presentation by requesting it through Aegis during the conference. DSS operates in sectors such as blockchain security, healthcare, and renewable energy, focusing on sustainable growth and value creation through innovative solutions.
DSS, Inc. (NYSE American: DSS) has entered a stock purchase agreement with Alset EHome International, Inc. to issue up to 44,619,423 shares at $0.3810 each, pending shareholder approval. CEO Frank D. Heuszel described this as a strong vote of confidence that will enhance the company's balance sheet, enabling it to pursue growth opportunities across multiple sectors. COO Jason Grady emphasized the efforts to build a foundation for shareholder value creation, gearing up for the next phase of growth focused on top-line and bottom-line performance.
DSS has announced a significant acquisition by adding True Partner Capital with assets under management (AUM) of $1.7 billion into its financial services arm, DSS Securities. The acquisitions include 877 million shares from Alset EHome International in exchange for newly issued shares of DSS. Following these transactions, Alset will become the majority shareholder with a 55.52% stake. This strategic move aims to enhance growth in DSS's securities business and leverage True Partner's established platform for tailored customer solutions.
DSS, Inc. has announced its subsidiary, American Medical REIT Inc. (AMRE), acquired a 21,900 sq. ft. medical office building in Winter Haven, Florida. The primary tenant, Palm Medical Center, has a six-year lease with 1% annual rent increases. The acquisition enhances AMRE's portfolio, which now exceeds 380,000 sq. ft. of healthcare assets. Additionally, AMRE received a $4.8 million loan from American Pacific Bancorp, with detachable warrants for common stock at $10/share. This move underscores DSS's strategy in resilient medical real estate despite pandemic challenges.
Impact Biomedical, a subsidiary of DSS, has announced the development of eco-friendly bio-plastics designed to resist viruses and reduce environmental impact. Founder Daryl Thompson and his team are isolating natural compounds to enhance plastics' resistance to harmful microorganisms.
Early tests show promising anti-microbial effects against SARS-CoV-2, achieving a 90% reduction in 30 minutes and 99% in 2 hours. These bioplastics aim to address global plastic pollution and have potential applications in various sectors, with the antimicrobial market projected to reach $17.55 billion by 2026.
Value Exchange International, Inc. (OTCQB: VEII) has appointed Mr. Heng Fai Ambrose Chan to its Board of Directors as a non-executive director. Mr. Chan brings over 45 years of experience in financial restructuring and corporate transformation, having successfully restructured more than 35 companies across various sectors. Notably, five of these companies have a combined market capitalization exceeding USD 18 billion and generate over USD 1.4 billion in annual profits. This appointment is expected to enhance the company's leadership and strategic direction.
DSS, Inc. has announced the near completion of a 105,000 sq. ft. facility for its subsidiary, Premier Packaging Corporation, located in Henrietta, NY. This expansion, scheduled to start operations on February 1, 2022, more than doubles Premier's existing capacity. The investment includes approximately $12 million in CAPEX, aimed at improving production efficiency and increasing staffing by over 50%. Premier specializes in sustainable fiber-based packaging solutions, targeting a growing customer demand while minimizing environmental impacts.
DSS, Inc. (NYSE American: DSS) announced that its subsidiary, American Pacific Bancorp (APB), has issued nearly $20 million in new loans since September 2021. CEO Frank D. Heuszel highlighted the diversified loan portfolio, which includes commercial real estate financing and equipment loans. APB targets businesses with annual revenues between $5 million to over $50 million across various sectors. DSS holds over 50% of APB's shares, with plans to expand its lending network and serve clients globally, particularly in underserved markets.
DSS, Inc. (NYSE American: DSS) has opened a new office in Sacramento, California, serving as the headquarters for DSS Wealth Management and DSS AmericaFirst Quantitative Funds. This strategic move is expected to enhance sales and marketing efforts, capitalizing on strong growth potential in the wealth management sector. DSS AmericaFirst offers various mutual funds aiming to outperform benchmarks through quantitative strategies. The firm continues to diversify its portfolio to drive profitability across several high-growth sectors, including blockchain security and renewable energy.